The Palico Private Equity Fund Marketplace

Paul Capital Partners

Paul Capital Partners logo

About Paul Capital Partners

Paul Capital Partners is a private equity general partner firm headquartered in San Francisco, CA, United States.

Fund performance

Paul Capital Partners fund performance

Analyze the track record of Paul Capital Partners

Paul Capital Partners funds

Want to see if Paul Capital Partners is fundraising? You need to be a PE professional to view this information. Register now for your free membership.
Closed and liquidated funds managed by Paul Capital Partners:
Fund name Size Vintage Status
Paul Capital Top Tier Investments V USD 400m 2011 Closed
Paul Capital Top Tier Special Opportunities Fund USD 36m 2009 Closed
Paul Capital Top Tier Investments IV USD 455m 2008 Closed
Paul Capital Partners IX USD 1,650m 2007 Closed
Paul Capital Healthcare III USD 650m 2006 Closed
Nova/Paul Capital Investments - 2005 Closed
Paul Capital Top Tier Investments III USD 620m 2005 Closed
CPP Investment Board - Paul Capital Holdings II USD 310m 2004 Closed
Paul Capital Partners VIII USD 960m 2004 Closed
Paul Capital Partners VIII B USD 50m 2004 Closed
Paul Royalty Fund II USD 657m 2003 Closed
Paul Capital Partners Top Tier Investment II USD 500m 2002 Closed
Paul Capital Partners VII USD 800m 2001 Closed
Paul Capital Royalty Acquisition Fund USD 300m 2000 Closed
Paul Royalty Fund I USD 300m 2000 Closed
Paul Capital Partners Top Tier Investment I USD 280m 1999 Liquidated
Paul Capital Partners VI USD 270m 1998 Closed
Paul Capital Partners Cayman Limited USD 48m 1997 Liquidated
Paul Capital Partners IV-A - 1996 Liquidated
Paul Capital Partners III USD 3m 1995 Liquidated
Paul Capital Partners IV USD 9m 1995 Liquidated
Paul Capital Partners V USD 202m 1995 Liquidated
Paul Capital Acquisition Fund - 1993 Closed
Paul Capital Partners USD 63m 1991 Liquidated

Paul Capital Partners portfolio

A sampling of Paul Capital Partners portfolio companies:

Acorda Therapeutics
United States
Aston University
United Kingdom
Avant Immunotherapeutics (now Celledex Therapeutics)
United States
Cancer Research Technology (CRT)
United Kingdom

A sampling of Paul Capital Partners portfolio funds:

Ideiasnet FIP 1
Ideiasnet

View all of the investments in their portfolio

Discover where LPs go for (more) PE and GPs get an inside edge
  • Access a comprehensive set of global fundraisings
  • Analyze 20,000 funds and promote your own
  • Contact LPs and GPs around the world
Join now

Registration is fast, free and easy

Already a member? Sign in